<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22793" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hepatitis E</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Waqar</surname>
            <given-names>Sana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Bashar</given-names>
          </name>
          <aff>SUNY Upstate University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Koirala</surname>
            <given-names>Janak</given-names>
          </name>
          <aff>Southern IL Un School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sana Waqar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bashar Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Janak Koirala declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22793.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hepatitis E virus (HEV) is classified in the genus Orthohepevirus of the Hepeviridae family and is one of the most common causes of hepatitis in the world. It causes acute, self-limited hepatitis in immunocompetent hosts and chronic hepatitis in immunosuppressed patients. This activity illustrates the evaluation and management of hepatitis E infection and reviews the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the epidemiology of hepatitis E infection.</p></list-item><list-item><p>Identify the typical history and presentation in patients with hepatitis E infection.</p></list-item><list-item><p>Review the 2018 EASL guidelines in the evaluation of hepatitis E infection.</p></list-item><list-item><p>Summarize the importance of improving care coordination among the interprofessional team to enhance the delivery of care and improve outcomes for patients affected by hepatitis E infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22793&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22793">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22793.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. Due to nonspecific symptoms and a self-limited disease course, it is also not frequently diagnosed. HEV is classified in the genus <italic toggle="yes">Orthohepevirus </italic>of the<italic toggle="yes"> Hepeviridae</italic> family. It is an icosahedral, nonenveloped virus. HEV has a single-stranded positive-sense RNA genome that is approximately 27 to 34 nm in diameter.<xref ref-type="bibr" rid="article-22793.r1">[1]</xref><xref ref-type="bibr" rid="article-22793.r2">[2]</xref><xref ref-type="bibr" rid="article-22793.r3">[3]</xref>&#x000a0;HEV is mainly transmitted via the fecal-oral route. It typically causes acute, self-limited hepatitis in normal hosts. It can also cause chronic hepatitis in immunosuppressed patients. It is associated with a higher mortality rate compared to acute hepatitis A virus infection, which is also transmitted via the enteric route. HEV infection can cause high mortality in pregnant females. The first evidence of an enterically transmitted viral hepatitis distinct from the hepatitis A virus (HAV) came from studies of a waterborne hepatitis epidemic in the late 1970s in Kashmir, India. It was initially identified as a non-A, non-B hepatitis (NANBH). Khuroo determined that the patients involved in the epidemic lacked serological evidence of acute hepatitis A, thereby&#x000a0;raising concern that another infective agent likely caused the outbreak.<xref ref-type="bibr" rid="article-22793.r4">[4]</xref>&#x000a0;Three years later,&#x000a0;Balayan and colleagues confirmed the existence of a new virus with enteric transmission.<xref ref-type="bibr" rid="article-22793.r1">[1]</xref>&#x000a0;NANB hepatitis was later called Hepatitis E to conform to the accepted nomenclature of other hepatitis viruses.</p>
      </sec>
      <sec id="article-22793.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hepatitis E virus (HEV) is an icosahedral, nonenveloped, single-stranded RNA virus that is approximately 27 to 34 nm in diameter. There are four identified genotypes of HEV, 1-4. Genotypes 1 and 2 are human viruses transmitted through the fecal-oral route from contaminated water and are found mainly in developing countries in Africa, Asia, Central America, and the Middle East. Genotypes 3 and 4 are mainly found in animals (zoonotic), transmitted to humans by eating undercooked meat such as pork and deer, and are mainly found in developed countries such as the United States, Australia, Japan, and China.<xref ref-type="bibr" rid="article-22793.r5">[5]</xref> Genotypes 1 and 2 are&#x000a0;usually seen in young adults (15-40) as part of outbreaks, causing acute infection that is self-limited and does not progress to chronic infection. However, acute infections in pregnant patients or patients with chronic liver disease can be&#x000a0;severe, with progression to fulminant liver failure.<xref ref-type="bibr" rid="article-22793.r5">[5]</xref> Genotypes 3 and 4 usually cause&#x000a0;sporadic cases and are mainly seen in older adults (older than 40). They can cause acute infections with a possibility of progression to chronic infections, mainly in immunocompromised patients such as solid organ transplant patients on immunosuppressants and HIV patients with AIDs.<xref ref-type="bibr" rid="article-22793.r5">[5]</xref></p>
      </sec>
      <sec id="article-22793.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>According to the World Health Organization (WHO), Hepatitis E virus (HEV) causes about 20 million new infections and over 55,000 deaths annually. HEV infection has a global distribution; however, it is most common in developing countries. The highest incidence of HEV infection is in Asia, Africa, the Middle East, and Central America.<xref ref-type="bibr" rid="article-22793.r6">[6]</xref><xref ref-type="bibr" rid="article-22793.r7">[7]</xref><xref ref-type="bibr" rid="article-22793.r8">[8]</xref>&#x000a0;HEV is the second most common cause of sporadic hepatitis in North Africa and the Middle East.<xref ref-type="bibr" rid="article-22793.r9">[9]</xref>&#x000a0;Sporadic cases have been described in Western countries and have mostly been limited to visitors who have traveled to HEV-endemic areas.<xref ref-type="bibr" rid="article-22793.r10">[10]</xref><xref ref-type="bibr" rid="article-22793.r11">[11]</xref><xref ref-type="bibr" rid="article-22793.r12">[12]</xref>&#x000a0;The overall seroprevalence of HEV in the US was estimated at&#x000a0;6% between 2009 and 2010.&#x000a0;The risk of HEV seropositivity is related to&#x000a0;increasing age, birth outside of&#x000a0;the United States, Hispanic race, and consumption of meat&#x000a0;(&#x0003e;10 times/month).<xref ref-type="bibr" rid="article-22793.r13">[13]</xref>&#x000a0;Although HEV was previously thought to be prevalent only in the developing countries of Asia and Africa, more recently, it has been found to be a zoonotic disease prevalent in high-income countries of Europe, where it is acquired from pigs.<xref ref-type="bibr" rid="article-22793.r14">[14]</xref></p>
      </sec>
      <sec id="article-22793.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hepatitis E virus (HEV)&#x000a0;is most commonly transmitted via the fecal-oral route from contaminated water, and large waterborne outbreaks frequently occur, especially in developing countries. Rarely, it can also be a fecally transmitted zoonotic infection.<xref ref-type="bibr" rid="article-22793.r15">[15]</xref>&#x000a0;Person-to-person transmission is rare. HEV can also&#x000a0;be transmitted by blood transfusion, particularly in endemic areas.<xref ref-type="bibr" rid="article-22793.r16">[16]</xref>&#x000a0;HEV can be transmitted vertically from infected mothers to their infants and can result in significant&#x000a0;perinatal mortality and fetal loss.<xref ref-type="bibr" rid="article-22793.r17">[17]</xref>&#x000a0;There is insufficient data regarding the transmission of HEV via breast milk; however, HEV has been isolated in breast milk, and serum titers were noted to be comparable <xref ref-type="bibr" rid="article-22793.r18">[18]</xref>.</p>
        <p>The incubation period of HEV infection ranges from 28 to 40 days. After ingestion, the virus is absorbed through the gastrointestinal mucosa into the portal circulation to reach the liver. HEV replication has not been observed in tissues other than the liver. HEV can produce morphologic changes in the liver that resemble both cholestatic and classic acute hepatitis, but these features are not diagnostic for hepatitis E.<xref ref-type="bibr" rid="article-22793.r19">[19]</xref>&#x000a0;HEV is excreted in feces.</p>
      </sec>
      <sec id="article-22793.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Hepatitis E virus (HEV) most commonly causes an acute illness that is typically indistinguishable from other forms of acute hepatitis. A vast majority of patients are asymptomatic or have a mild clinical&#x000a0;disease.&#x000a0;When clinical signs and symptoms&#x000a0;develop, they&#x000a0;are similar to those seen with other forms of acute viral hepatitis, such as malaise, anorexia, nausea, vomiting, jaundice, and abdominal pain. Clinical examination is nonspecific. Patients may appear acutely ill with jaundice.&#x000a0;Right upper quadrant abdominal tenderness and hepatomegaly may be present.</p>
        <p>HEV should be considered in any patient with symptoms of acute hepatitis who&#x000a0;is from a country with a high incidence of HEV or has a history of recent travel to an endemic country. The disease is more common in adults than in children. Pregnant patients have more severe symptoms. Generally, HEV causes a self-limited infection in immunocompetent individuals. Chronic hepatitis does not develop after acute HEV infection, except in immunocompromised patients such as transplant recipients. Due to their ongoing immunosuppression, transplant patients are unable to clear the virus and develop chronic hepatitis, with a risk of&#x000a0;eventually&#x000a0;developing cirrhosis.<xref ref-type="bibr" rid="article-22793.r20">[20]</xref></p>
        <p>When fulminant hepatitis occurs, it can result in an overall case fatality rate of 0.5% to 3%.<xref ref-type="bibr" rid="article-22793.r21">[21]</xref>&#x000a0;Patients can also have extrahepatic manifestations such as thrombocytopenia, hemolysis, aplastic anemia, acute thyroiditis, membranous glomerulonephritis, and neurological diseases such as acute transverse myelitis and septic meningitis.<xref ref-type="bibr" rid="article-22793.r22">[22]</xref></p>
      </sec>
      <sec id="article-22793.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Accurate diagnosis requires a high index of clinical suspicion. Hepatitis E virus (HEV)&#x000a0;should be&#x000a0;considered&#x000a0;in recent travelers or patients from endemic countries. HEV should also be considered in patients with acute hepatitis who&#x000a0;are at risk of serious complications, such as patients with underlying liver disease, pregnant women, and immunocompromised patients.</p>
        <p>Laboratory findings include elevated serum concentrations of bilirubin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Laboratory diagnosis of HEV infection is difficult due to the&#x000a0;lack of standardized&#x000a0;testing. Many commercial kits have been developed to test for anti-HEV IgM and IgG, but the utility&#x000a0;is limited as there are many false positives and negatives. In general, diagnosis of acute HEV infection can be made with a positive serum HEV IgM in the right clinical setting.<xref ref-type="bibr" rid="article-22793.r23">[23]</xref>&#x000a0;Patients should also be tested for other viral hepatitis such as A, B, and C. Definitive diagnosis is made with the detection of HEV in serum or stool by polymerase chain reaction (PCR). Because the viremia from HEV&#x000a0;can be&#x000a0;relatively short-lived, especially in immunocompetent patients, a negative HEV PCR does not exclude the possibility of recent HEV infection. Serology may be more beneficial in these cases. The role of serological testing is, however, limited in immunocompromised individuals who may not mount&#x000a0;an antibody response. PCR testing should be the cornerstone of diagnosis in this patient population.<xref ref-type="bibr" rid="article-22793.r24">[24]</xref><xref ref-type="bibr" rid="article-22793.r25">[25]</xref><xref ref-type="bibr" rid="article-22793.r26">[26]</xref>&#x000a0;Diagnosis of chronic HEV infection can be made by the persistent isolation of HEV RNA in the serum or stool after 6 months of initial infection.</p>
        <p>In European countries, the 2018 EASL (European Association for the Study of the Liver) guidelines recommend both serology and NAT (nucleic acid amplification technique) for the diagnosis of acute HEV infection and NAT for the diagnosis of chronic HEV infection.<xref ref-type="bibr" rid="article-22793.r14">[14]</xref></p>
      </sec>
      <sec id="article-22793.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Acute Hepatitis E virus (HEV) infection is generally&#x000a0;self-limited and requires only supportive care. Resolution of the abnormal biochemical tests generally&#x000a0;occurs within one to 6 weeks after the onset of the illness; however, patients who do&#x000a0;develop fulminant liver failure need liver transplantation. The role of antiviral therapy, such as ribavirin,&#x000a0;for acute HEV infection in immunocompromised patients is uncertain. Ribavirin should not be used in patients who are pregnant and have&#x000a0;acute HEV infection due to the risk of teratogenicity. In patients who are immunocompromised and have chronic HEV infection, modification in immunosuppressive medication and use of anti-viral drugs, such as ribavirin, peginterferon, or both, is recommended.<xref ref-type="bibr" rid="article-22793.r26">[26]</xref><xref ref-type="bibr" rid="article-22793.r27">[27]</xref></p>
      </sec>
      <sec id="article-22793.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis includes other forms of viral hepatitis, such as hepatitis A, B, or C; CMV; drug or toxic hepatitis; ischemic hepatitis; and other infectious diseases in endemic areas, such as leptospirosis, dengue, yellow fever, and malaria.</p>
      </sec>
      <sec id="article-22793.s10" sec-type="Complications">
        <title>Complications</title>
        <p>HEV is typically a self-limited disease. Some patients, however, may develop acute complications such as acute hepatic failure, cholestatic jaundice, or chronic HEV infection. Extrahepatic manifestations have been reported with genotype 3, which is mainly neurological, including inflammatory polyradiculopathy, Guillain-Barr&#x000e9; syndrome, peripheral neuropathy, encephalitis, and ataxia.&#x000a0;<xref ref-type="bibr" rid="article-22793.r28">[28]</xref></p>
      </sec>
      <sec id="article-22793.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>An interprofessional team approach, including infectious diseases and hepatology, would be beneficial to patients who are immunocompromised and have an acute or chronic HEV infection.</p>
      </sec>
      <sec id="article-22793.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Due to the lack of specific clinical signs and symptoms, the diagnosis of HEV infection is difficult. One complication is the lack of standardized&#x000a0;testing. High clinical suspicion is, therefore, required for timely diagnosis. Fortunately, for most immunocompetent patients, the infection is self-limited and only requires supportive care. Special attention, however,&#x000a0;is needed for certain high-risk patient groups, such as patients who are pregnant, immunocompromised, and those with an&#x000a0;underlying liver disease. HEV infection should be considered in these patients if they have acute hepatitis and workup for other causes is unrevealing, especially if they have a history of travel to an endemic area.</p>
        <p>Immunocompromised patients with acute or chronic HEV infection should be managed by an interprofessional team, including consultation from infectious diseases, hepatology, and oncology.</p>
        <p>The most important measure to prevent HEV infection is protecting water supplies from contamination with human feces. Travelers to endemic regions must take precautions against the consumption of contaminated water, ice, and food. Women should try to avoid unnecessary travel to endemic areas during pregnancy. Vaccines against hepatitis E virus (HEV239) are available in China but&#x000a0;are not FDA-approved.<xref ref-type="bibr" rid="article-22793.r29">[29]</xref><xref ref-type="bibr" rid="article-22793.r30">[30]</xref>&#x000a0;Research is limited regarding the efficacy of pre- or post-exposure immunoglobulin prophylaxis for the prevention of HEV in humans.<xref ref-type="bibr" rid="article-22793.r31">[31]</xref></p>
      </sec>
      <sec id="article-22793.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22793&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22793">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/hepatitis-e/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22793">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22793/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22793">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22793.s14">
        <title>References</title>
        <ref id="article-22793.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balayan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Andjaparidze</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Savinskaya</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ketiladze</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Braginsky</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Savinov</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Poleschuk</surname>
                <given-names>VF</given-names>
              </name>
            </person-group>
            <article-title>Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route.</article-title>
            <source>Intervirology</source>
            <year>1983</year>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-31</page-range>
            <pub-id pub-id-type="pmid">6409836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kane</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Maynard</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets.</article-title>
            <source>JAMA</source>
            <year>1984</year>
            <month>Dec</month>
            <day>14</day>
            <volume>252</volume>
            <issue>22</issue>
            <fpage>3140</fpage>
            <page-range>3140-5</page-range>
            <pub-id pub-id-type="pmid">6438353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyazaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Unno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moriishi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsukihara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miyamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsuura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2009</year>
            <month>Aug</month>
            <day>04</day>
            <volume>106</volume>
            <issue>31</issue>
            <fpage>12986</fpage>
            <page-range>12986-91</page-range>
            <pub-id pub-id-type="pmid">19620712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khuroo</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.</article-title>
            <source>Am J Med</source>
            <year>1980</year>
            <month>Jun</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>818</fpage>
            <page-range>818-24</page-range>
            <pub-id pub-id-type="pmid">6770682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoofnagle</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Sep</month>
            <day>27</day>
            <volume>367</volume>
            <issue>13</issue>
            <fpage>1237</fpage>
            <page-range>1237-44</page-range>
            <pub-id pub-id-type="pmid">23013075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arankalle</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Chadha</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mehendale</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Outbreak of enterically transmitted non-A, non-B hepatitis among schoolchildren.</article-title>
            <source>Lancet</source>
            <year>1988</year>
            <month>Nov</month>
            <day>19</day>
            <volume>2</volume>
            <issue>8621</issue>
            <fpage>1199</fpage>
            <page-range>1199-200</page-range>
            <pub-id pub-id-type="pmid">2903413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsega</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Krawczynski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Nordenfelt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Negusse</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Alemu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bahru</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia.</article-title>
            <source>J Med Virol</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-6</page-range>
            <pub-id pub-id-type="pmid">1940876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vel&#x000e1;zquez</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Stetler</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Avila</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ornelas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hadler</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Sep&#x000fa;lveda</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987.</article-title>
            <source>JAMA</source>
            <year>1990</year>
            <month>Jun</month>
            <day>27</day>
            <volume>263</volume>
            <issue>24</issue>
            <fpage>3281</fpage>
            <page-range>3281-5</page-range>
            <pub-id pub-id-type="pmid">2112204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Emerson</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Running like water--the omnipresence of hepatitis E.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Dec</month>
            <day>02</day>
            <volume>351</volume>
            <issue>23</issue>
            <fpage>2367</fpage>
            <page-range>2367-8</page-range>
            <pub-id pub-id-type="pmid">15575050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Hepatitis E among U.S. travelers, 1989-1992.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>1993</year>
            <month>Jan</month>
            <day>15</day>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">8418395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Cock</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Sandford</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Govindarajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maynard</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Redeker</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Epidemic non-A, non-B hepatitis in patients from Pakistan.</article-title>
            <source>Ann Intern Med</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>106</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-30</page-range>
            <pub-id pub-id-type="pmid">3099621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fortier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Treadwell</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Koff</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Enterically transmitted non-A, non-B hepatitis: importation from Mexico to Massachusetts.</article-title>
            <source>N Engl J Med</source>
            <year>1989</year>
            <month>May</month>
            <day>11</day>
            <volume>320</volume>
            <issue>19</issue>
            <fpage>1281</fpage>
            <page-range>1281-2</page-range>
            <pub-id pub-id-type="pmid">2496311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ditah</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ditah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Devaki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ditah</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Charlton</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey.</article-title>
            <source>Hepatology</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>815</fpage>
            <page-range>815-22</page-range>
            <pub-id pub-id-type="pmid">24824965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <collab>European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu</collab>
            <collab>European Association for the Study of the Liver</collab>
            <article-title>EASL Clinical Practice Guidelines on hepatitis E virus infection.</article-title>
            <source>J Hepatol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>1256</fpage>
            <page-range>1256-1271</page-range>
            <pub-id pub-id-type="pmid">29609832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kitajima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mishiro</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Zoonotic transmission of hepatitis E virus from deer to human beings.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Aug</month>
            <day>02</day>
            <volume>362</volume>
            <issue>9381</issue>
            <fpage>371</fpage>
            <page-range>371-3</page-range>
            <pub-id pub-id-type="pmid">12907011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khuroo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kamili</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yattoo</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>778</fpage>
            <page-range>778-84</page-range>
            <pub-id pub-id-type="pmid">15209625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khuroo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kamili</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jameel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Vertical transmission of hepatitis E virus.</article-title>
            <source>Lancet</source>
            <year>1995</year>
            <month>Apr</month>
            <day>22</day>
            <volume>345</volume>
            <issue>8956</issue>
            <fpage>1025</fpage>
            <page-range>1025-6</page-range>
            <pub-id pub-id-type="pmid">7723501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivero-Juarez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frias</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodriguez-Cano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cuenca-L&#x000f3;pez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rivero</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Isolation of Hepatitis E Virus From Breast Milk During Acute Infection.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Jun</month>
            <day>01</day>
            <volume>62</volume>
            <issue>11</issue>
            <fpage>1464</fpage>
            <pub-id pub-id-type="pmid">27025819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bendall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Legrand-Abravanel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Ijaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Izopet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Jun</month>
            <day>30</day>
            <volume>379</volume>
            <issue>9835</issue>
            <fpage>2477</fpage>
            <page-range>2477-2488</page-range>
            <pub-id pub-id-type="pmid">22549046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halac</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>B&#x000e9;land</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lapierre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Patey</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brassard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Houde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant.</article-title>
            <source>J Pediatr</source>
            <year>2012</year>
            <month>May</month>
            <volume>160</volume>
            <issue>5</issue>
            <fpage>871</fpage>
            <page-range>871-4.e1</page-range>
            <pub-id pub-id-type="pmid">22341950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control (CDC)</collab>
            <article-title>Enterically transmitted non-A, non-B hepatitis--East Africa.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>1987</year>
            <month>May</month>
            <day>01</day>
            <volume>36</volume>
            <issue>16</issue>
            <fpage>241</fpage>
            <page-range>241-4</page-range>
            <pub-id pub-id-type="pmid">3104762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geurtsvankessel</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mohammad</surname>
                <given-names>QD</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Endtz</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Osterhaus</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E and Guillain-Barre syndrome.</article-title>
            <source>Clin Infect Dis</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>9</issue>
            <fpage>1369</fpage>
            <page-range>1369-70</page-range>
            <pub-id pub-id-type="pmid">23899686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kusakai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mizuo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fujimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Masuko</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sugai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.</article-title>
            <source>J Clin Microbiol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-56</page-range>
            <pub-id pub-id-type="pmid">15634950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baylis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hanschmann</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bl&#x000fc;mel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000fc;bling</surname>
                <given-names>CM</given-names>
              </name>
              <collab>HEV Collaborative Study Group</collab>
            </person-group>
            <article-title>Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance.</article-title>
            <source>J Clin Microbiol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>1234</fpage>
            <page-range>1234-9</page-range>
            <pub-id pub-id-type="pmid">21307208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khudyakov</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kamili</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Serological diagnostics of hepatitis E virus infection.</article-title>
            <source>Virus Res</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>161</volume>
            <issue>1</issue>
            <fpage>84</fpage>
            <page-range>84-92</page-range>
            <pub-id pub-id-type="pmid">21704091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khuroo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Khuroo</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E: an emerging global disease - from discovery towards control and cure.</article-title>
            <source>J Viral Hepat</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>68</fpage>
            <page-range>68-79</page-range>
            <pub-id pub-id-type="pmid">26344932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garrouste</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haagsma</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Garrigue</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pischke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chauvet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dumortier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cannesson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cassuto-Viguier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thervet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lebray</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Santella</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kanaan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Essig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mousson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Radenne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roque-Afonso</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Izopet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rostaing</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.</article-title>
            <source>Gastroenterology</source>
            <year>2011</year>
            <month>May</month>
            <volume>140</volume>
            <issue>5</issue>
            <fpage>1481</fpage>
            <page-range>1481-9</page-range>
            <pub-id pub-id-type="pmid">21354150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bendall</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Peron</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cintas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prudhomme</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mansuy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rostaing</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ijaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Izopet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis E virus and neurologic disorders.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-9</page-range>
            <pub-id pub-id-type="pmid">21291585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <article-title>Hepatitis E vaccine: WHO position paper, May 2015.</article-title>
            <source>Wkly Epidemiol Rec</source>
            <year>2015</year>
            <month>May</month>
            <day>01</day>
            <volume>90</volume>
            <issue>18</issue>
            <fpage>185</fpage>
            <page-range>185-200</page-range>
            <pub-id pub-id-type="pmid">25935931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>XF</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZZ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ai</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xian</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Miao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.</article-title>
            <source>Lancet</source>
            <year>2010</year>
            <month>Sep</month>
            <day>11</day>
            <volume>376</volume>
            <issue>9744</issue>
            <fpage>895</fpage>
            <page-range>895-902</page-range>
            <pub-id pub-id-type="pmid">20728932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22793.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsarev</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Tsareva</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Emerson</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Govindarajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Successful passive and active immunization of cynomolgus monkeys against hepatitis E.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1994</year>
            <month>Oct</month>
            <day>11</day>
            <volume>91</volume>
            <issue>21</issue>
            <fpage>10198</fpage>
            <page-range>10198-202</page-range>
            <pub-id pub-id-type="pmid">7937861</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
